Steven Ramsay, MD | |
401 Medical Park Dr, Atmore, AL 36502-3006 | |
(904) 805-1300 | |
(904) 805-1302 |
Full Name | Steven Ramsay |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 32 Years |
Location | 401 Medical Park Dr, Atmore, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588603211 | NPI | - | NPPES |
P00359276 | Other | RAILROAD MCR | |
00084401F | Medicaid | GA | |
000844401B | Medicaid | GA | |
P00332193 | Other | RAILROAD MCR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 16790 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Medical Center Enterprise | Enterprise, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Southern Alabama Physicians, Llp | 0345499562 | 11 |
News Archive
Flooded with new health information every week, patients and their doctors look for ways to sort the best from the rest.
Covidien, a leading global provider of healthcare products and a world leader in advanced energy-based devices, today announced a definitive agreement to acquire BÂRRX Medical, Inc. BÂRRX is the leader in treatment of Barrett's esophagus syndrome using bipolar radiofrequency (RF) ablation devices.
People are not the only ones suffering from the symptoms and problems of food intolerance and allergies.
AMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity. The announcement was made yesterday during a presentation by AMRI's Dr. Peter Guzzo, director, discovery research and development, at the 6th Obesity and Diabetes Drug Development Summit in Arlington, VA. Preclinical data were also reported.
› Verified 4 days ago
Entity Name | App Of Alabama Ed Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1659646040 PECOS PAC ID: 3577725068 Enrollment ID: O20120430000174 |
News Archive
Flooded with new health information every week, patients and their doctors look for ways to sort the best from the rest.
Covidien, a leading global provider of healthcare products and a world leader in advanced energy-based devices, today announced a definitive agreement to acquire BÂRRX Medical, Inc. BÂRRX is the leader in treatment of Barrett's esophagus syndrome using bipolar radiofrequency (RF) ablation devices.
People are not the only ones suffering from the symptoms and problems of food intolerance and allergies.
AMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity. The announcement was made yesterday during a presentation by AMRI's Dr. Peter Guzzo, director, discovery research and development, at the 6th Obesity and Diabetes Drug Development Summit in Arlington, VA. Preclinical data were also reported.
› Verified 4 days ago
Entity Name | Southern Alabama Physicians, Llp |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467701490 PECOS PAC ID: 0345499562 Enrollment ID: O20121003000896 |
News Archive
Flooded with new health information every week, patients and their doctors look for ways to sort the best from the rest.
Covidien, a leading global provider of healthcare products and a world leader in advanced energy-based devices, today announced a definitive agreement to acquire BÂRRX Medical, Inc. BÂRRX is the leader in treatment of Barrett's esophagus syndrome using bipolar radiofrequency (RF) ablation devices.
People are not the only ones suffering from the symptoms and problems of food intolerance and allergies.
AMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity. The announcement was made yesterday during a presentation by AMRI's Dr. Peter Guzzo, director, discovery research and development, at the 6th Obesity and Diabetes Drug Development Summit in Arlington, VA. Preclinical data were also reported.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Steven Ramsay, MD Po Box 863535, Orlando, FL 32886-3535 Ph: (904) 805-1300 | Steven Ramsay, MD 401 Medical Park Dr, Atmore, AL 36502-3006 Ph: (904) 805-1300 |
News Archive
Flooded with new health information every week, patients and their doctors look for ways to sort the best from the rest.
Covidien, a leading global provider of healthcare products and a world leader in advanced energy-based devices, today announced a definitive agreement to acquire BÂRRX Medical, Inc. BÂRRX is the leader in treatment of Barrett's esophagus syndrome using bipolar radiofrequency (RF) ablation devices.
People are not the only ones suffering from the symptoms and problems of food intolerance and allergies.
AMRI has commenced enrollment for a Phase I study of ALB-127158(a), a novel MCH1 receptor antagonist offering a potential new approach for the treatment of obesity. The announcement was made yesterday during a presentation by AMRI's Dr. Peter Guzzo, director, discovery research and development, at the 6th Obesity and Diabetes Drug Development Summit in Arlington, VA. Preclinical data were also reported.
› Verified 4 days ago
Jeffrey Sloan, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 Medical Park Dr, Atmore, AL 36502 Phone: 904-805-1300 Fax: 904-805-1302 | |
Robert A M Revel, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 401 Medical Park Dr, Atmore, AL 36502 Phone: 904-805-1300 Fax: 904-805-1302 | |
Mark C D Mitchell, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 401 Medical Park Dr, Atmore, AL 36502 Phone: 904-805-1300 Fax: 904-805-1302 | |
Dr. Jay Steven Scarborough, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 401 Medical Park Dr, Atmore, AL 36502 Phone: 251-368-2500 |